SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-3 - Registration statement under Securities Act of 1933:
SEC Accession No. 0001193125-24-082065
Filing Date
2024-03-29
Accepted
2024-03-29 16:10:07
Documents
6

Document Format Files

Seq Description Document Type Size
1 S-3 d786443ds3.htm S-3 254196
2 EX-5.1 d786443dex51.htm EX-5.1 7060
3 EX-23.1 d786443dex231.htm EX-23.1 1733
4 EX-FILING FEES d786443dexfilingfees.htm EX-FILING FEES 30462
5 GRAPHIC g786443g0328123118385.jpg GRAPHIC 1915
6 GRAPHIC g786443g20x62.jpg GRAPHIC 61304
  Complete submission text file 0001193125-24-082065.txt   382076
Mailing Address 275 WYMAN STREET 3RD FLOOR WALTHAM MA 02451
Business Address 275 WYMAN STREET 3RD FLOOR WALTHAM MA 02451 617-945-5576
Cogent Biosciences, Inc. (Filer) CIK: 0001622229 (see all company filings)

IRS No.: 465308248 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-3 | Act: 33 | File No.: 333-278382 | Film No.: 24804218
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)